{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T13:55:04Z","timestamp":1694440504934},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.beha.2012.04.009","type":"journal-article","created":{"date-parts":[[2012,5,30]],"date-time":"2012-05-30T18:46:23Z","timestamp":1338403583000},"page":"153-163","source":"Crossref","is-referenced-by-count":5,"title":["Murine models in mantle cell lymphoma"],"prefix":"10.1016","volume":"25","author":[{"given":"Kelly","family":"Zullo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer E.","family":"Amengual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen A.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Scotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2012.04.009_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","article-title":"Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in genomic era","volume":"117","author":"Perez-Galan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.04.009_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.semcancer.2011.09.009","article-title":"Unlocking the secrets of immunoglobin receptors in mantle cell lymphoma: implications for the origin and selection of malignant cells","volume":"21","author":"Agathangelids","year":"2011","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.beha.2012.04.009_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0165-4608(02)00624-6","article-title":"Clonal development of a blastoid mantle cell lymphoma studied with comparative genomic hybridization","volume":"139","author":"Flordal","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.beha.2012.04.009_bib4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1365-2141.2003.04761.x","article-title":"Molecular basis of mantle cell lymphoma","volume":"124","author":"Bertoni","year":"2004","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.beha.2012.04.009_bib5","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood.V83.7.1871.1871","article-title":"Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas","volume":"83","author":"Rimokh","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.04.009_bib6","unstructured":"Fogli L, Williams M, Connors J, et\u00a0al. Development and characterization of a mantle cell lymphoma cell bank in the American type culture collection. Submitted to Clinical Cancer Research, 2011."},{"issue":"2","key":"10.1016\/j.beha.2012.04.009_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cancergencyto.2004.01.006","article-title":"Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519","volume":"153","author":"Rudolph","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"issue":"8","key":"10.1016\/j.beha.2012.04.009_bib8","first-page":"449","article-title":"The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma","volume":"105","author":"Katzenberger","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.beha.2012.04.009_bib9","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.leukres.2005.11.013","article-title":"Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines","volume":"30","author":"Camps","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2012.04.009_bib10","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1158\/1078-0432.CCR-09-1937","article-title":"Romidepsin and Belinostat synergize the antineoplastic effect of bortezomib in mantle cell lymphoma","volume":"16","author":"Paoluzzi","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2012.04.009_bib11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/ajh.23112","article-title":"The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients","volume":"87","author":"Kelly-Sell","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beha.2012.04.009_bib12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.leukres.2010.09.027","article-title":"Lenalidomide synergizes with dexamethasone to induce growth arrest and apoptosis of mantle cell lymphoma cells in\u00a0vitro and in\u00a0vivo","volume":"35","author":"Qian","year":"2011","journal-title":"Leuk Res"},{"issue":"7","key":"10.1016\/j.beha.2012.04.009_bib13","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1158\/1078-0432.CCR-07-4409","article-title":"A severe combined immunodeficient-hu in\u00a0vivo mouse model of human primary mantle cell lymphoma","volume":"14","author":"Wang","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.beha.2012.04.009_bib14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/labinvest.3780061","article-title":"Development of intermediate-grade (mantle cell) and low-grade (small lymphocytic and marginal zone) human non-Hodgkin's lymphomas xenotransplanted in severe combined immunodeficieny mouse models","volume":"80","author":"Bryant","year":"2000","journal-title":"Lab Invest"},{"key":"10.1016\/j.beha.2012.04.009_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-4608(02)00823-3","article-title":"Blastoid mantle cell lymphoma: evidence for nonrandom cytogenic abnormalities additional to t(11;14) and generation of a mouse model","volume":"143","author":"M'kacher","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"issue":"15","key":"10.1016\/j.beha.2012.04.009_bib16","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1002\/j.1460-2075.1994.tb06655.x","article-title":"Cyclin D1\/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice","volume":"13","author":"Lovex","year":"1994","journal-title":"EMBO J"},{"issue":"9","key":"10.1016\/j.beha.2012.04.009_bib17","first-page":"212","article-title":"Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene","volume":"13","author":"Bodruge","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.beha.2012.04.009_bib18","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.onc.1209147","article-title":"Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma","volume":"25","author":"Gladden","year":"2006","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.beha.2012.04.009_bib19","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1182\/blood-2006-08-038497","article-title":"Development of a murine model for blastoid variant mantle cell lymphoma","volume":"109","author":"Ford","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.04.009_bib20","doi-asserted-by":"crossref","unstructured":"Scotto L, Kruithof-de J, Paoluzzi L, et\u00a0al. Development and characterization of a novel CD19-CherryLuciferase (CD19CL) transgenic mouse for the preclinical study of B-cell lymphomas. Submitted Clin Canc Res, Published online May 15, 2012.","DOI":"10.1158\/1078-0432.CCR-11-2588"},{"issue":"9","key":"10.1016\/j.beha.2012.04.009_bib21","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0145-2126(02)00013-9","article-title":"Establishment and characterization of a new mantle cell lymphoma cell line, Mino","volume":"26","author":"Lai","year":"2002","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.beha.2012.04.009_bib22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0145-2126(97)00191-4","article-title":"Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemia","volume":"22","author":"Estrov","year":"1998","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.beha.2012.04.009_bib23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/ijc.2910380413","article-title":"Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement","volume":"38","author":"Melo","year":"1986","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.beha.2012.04.009_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/gcc.2870080204","article-title":"Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies","volume":"8","author":"Raynaud","year":"1993","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"10.1016\/j.beha.2012.04.009_bib25","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1182\/blood.V72.6.2026.2026","article-title":"Characterization of a new non-Hodgkin's lymphoma cell line (NCEB-1) with a chromosomal (11:14) translocation [t(11:14)(q13;q32)]","volume":"72","author":"Saltman","year":"1988","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2012.04.009_bib26","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1046\/j.1365-2141.1998.00911.x","article-title":"Establishment and characterization of a mantle cell lymphoma cell line","volume":"102","author":"Jeon","year":"1998","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.beha.2012.04.009_bib27","first-page":"40","article-title":"Establishment of the MAVER-1 cell line, a model for leukemic and aggressive mantle cell lymphoma","volume":"91","author":"Zamo","year":"2006","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.beha.2012.04.009_bib28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/1097-0142(19880201)61:3<483::AID-CNCR2820610313>3.0.CO;2-L","article-title":"Characterization and comparison of two newly established Epstein-Barr virus-negative lymphoma B-cell lines. Surface markers, growth characteristics, cytogenetics, and transplantability","volume":"61","author":"Abe","year":"1988","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.beha.2012.04.009_bib29","first-page":"1182","article-title":"Establishment of a new human B cell line carrying t(11;14) chromosome abnormality","volume":"78","author":"Daibata","year":"1987","journal-title":"Jpn J Cancer Res"},{"issue":"9","key":"10.1016\/j.beha.2012.04.009_bib30","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0145-2126(02)00026-7","article-title":"Malignant hematopoietic cell lines: in\u00a0vitro models for the study of mantle cell lymphoma","volume":"26","author":"Drexler","year":"2002","journal-title":"Leuk Res"},{"issue":"6","key":"10.1016\/j.beha.2012.04.009_bib31","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/1097-0142(19890915)64:6<1248::AID-CNCR2820640614>3.0.CO;2-5","article-title":"The establishment of Epstein-Barr virus nuclear antigen-positive (SP-50B) and Epstein-Barr virus nuclear antigen-negative (SP-53) cell lines with t(11;14)(q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma","volume":"64","author":"Daibata","year":"1989","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.beha.2012.04.009_bib32","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1080\/10428190310001642729","article-title":"Establishment and characterization of a new mantle cell lymphoma cell line M-1","volume":"45","author":"Goy","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.beha.2012.04.009_bib33","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00280-007-0543-3","article-title":"Farnesytltransferase inhibitor R115777 inhibits cell growth and induces apoptosis in mantle cell lymphoma","volume":"61","author":"Rolland","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"10.1016\/j.beha.2012.04.009_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.leukres.2011.09.014","article-title":"Combination of atriprimod and the proteasome inhibitor bortezomin induces apoptosis of mantle cell lymphoma in\u00a0vitro and in\u00a0vivo","volume":"36","author":"Sun","year":"2012","journal-title":"Leuk Res"},{"issue":"2","key":"10.1016\/j.beha.2012.04.009_bib35","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1182\/blood-2011-04-346601","article-title":"Dual mTORC1\/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies","volume":"119","author":"Gupta","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.04.009_bib36","article-title":"Aurora A inhibitor (MLN8237) plus vincristine synergizes with rituximab as a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma","author":"Mahadean","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"15","key":"10.1016\/j.beha.2012.04.009_bib37","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1182\/blood-2011-03-340323","article-title":"HDM-2 inhibition suppresses expression fo ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine induced cytotoxcity in mantle cell lymphoma","volume":"118","author":"Jones","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2012.04.009_bib38","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1158\/1078-0432.CCR-09-2484","article-title":"FTY720 shows promising in\u00a0vitro and in\u00a0vivo preclinical activity by downmodulating cyclin D1 and phospho-AKT in mantle cell lymphoma","volume":"16","author":"Liu","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.beha.2012.04.009_bib39","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1158\/1535-7163.MCT-07-0302","article-title":"Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1 nuclear factor-kappaB, p53, bax, p27","volume":"7","author":"Tucker","year":"2008","journal-title":"Mol Cancer Ther"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692612000369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692612000369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T07:11:52Z","timestamp":1594192312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692612000369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1521692612000369"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2012.04.009","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}